Media

SEMA4 PRESS RELEASE | 08.10.17

Alexion and Sema4 Partner in Rare Disease Diagnostics and Systems Biology

“Alexion Pharmaceuticals, Inc. and Sema4 today announced a strategic partnership to leverage their shared experience in data science and systems biology to accelerate rare disease diagnosis and therapeutic discovery. This new partnership will combine Alexion’s rare disease SmartPanel analytics with Sema4’s proven success in next-generation sequencing and genomic interpretation to further enable novel diagnostic and therapeutic insights into rare diseases…”
READ THE ARTICLE
SEMA4 PRESS RELEASE | 07.24.17

Sema4 Partners with Helix to Launch CarrierCheck™: A New, Easy Way for Consumers to Access a Genetic Screen for 67 Hereditary Diseases

“Sema4 today announced the launch of CarrierCheck, a simple saliva-based test that provides individuals with a snapshot of how their DNA may affect their future children. CarrierCheck is the only carrier test that screens for 67 conditions that can be ordered by consumers online. It was developed in collaboration with Helix, a personal genomics company that today launched the first online marketplace for DNA-powered products…”
READ THE ARTICLE
SEMA4 PRESS RELEASE | 06.27.17

Sema4 and GNS Healthcare Announce Collaboration Using REFS™ Causal Machine Learning and Simulation AI Platform

“Sema4 and GNS will collaborate to maximize various data resources, such as longitudinal EMR records, next generation sequencing, proteomics, and other ‘omic data, to discover underlying drivers of cardiovascular disease. These insights may help identify existing treatments for cardiovascular conditions, as well as identify opportunities for the research and development of next-generation treatments….”
READ THE ARTICLE
SEMA4 PRESS RELEASE | 06.01.17

Introducing Sema4: A Spinout Company of the Mount Sinai Health System

“Sema4 is an interdisciplinary health information company that is committed to providing open access to data and creating practical tools that help patients, clinicians, and researchers better predict health trajectories…”
READ THE ARTICLE
XCONOMY | 06.01.17

Sema4, Eric Schadt’s Genomics Startup, Spins Out of Sinai to Raise Cash

“Eric Schadt has been incubating a genomic data project within the Icahn School of Medicine at Mount Sinai for more than five years. Today, the product of that work, a startup called Sema4, has formally left the nest…”
READ THE ARTICLE
SEMA4 VIDEO | 03.15.17

Sema4: Informing Your Health Today, Tomorrow, Together

“We have been able to demonstrate that by aggregating information, we can uncover new causes of diabetes and new subtypes in personalized cancer therapy…”
VIEW THE VIDEO
MOUNT SINAI PRESS RELEASE | 03.13.17

Mount Sinai Researchers Publish Results of First-of-Its-Kind iPhone Asthma Study

“The Asthma Mobile Health study represents the coming together of academia and industry to benefit from the ubiquity of smartphones and harness the power of citizen-science to modernize the clinical research process…”
READ THE ARTICLE
HUFFINGTON POST | 02.01.17

How Big Data Could Transform the Health Care Industry

“Data scientist Dr. Eric Schadt is on a mission to revolutionize health care. Leveraging the power of new technologies and mobile devices, he thinks the healthcare industry can be transformed the way Uber and AirBnB transformed the taxi and hotel industries…”
READ THE ARTICLEVIEW THE VIDEO
WIRED | 10.19.16

The Cure for Cancer Is Data – Mountains of Data

“The hope is that, ultimately, these increasingly sophisticated, increasingly patient-friendly tests will be so comprehensive that a patient’s microbiome can be regularly sequenced…”
READ THE ARTICLE
NATURE | 03.21.16

Mobile Phone Health Apps Deliver Data Bounty

“Smartphone apps developed by academics, pharmaceutical companies and technology giants are making possible large studies that collect real-time data on people’s location, environment and health…”
READ THE ARTICLE